Skip to main content
. 2023 Nov 15;28(22):7607. doi: 10.3390/molecules28227607

Figure 4.

Figure 4

Three-dimensional docking structures with EGFR of the candidate inhibitors (green) (a) TCMIO5312, (b) TCMIO89212, (c) TCMIO90156, (d) TCMIO98874, (e) HMDB0012243, (f) HMDB0014570, (g) HMDB0037450, and Erlotinib (red).